BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 10.2//EN
BEGIN:VTIMEZONE
TZID:W. Europe Standard Time
BEGIN:STANDARD
DTSTART:20251002T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=3;BYMINUTE=0;BYMONTH=10
TZNAME:W. Europe Standard Time
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:W. Europe Daylight Time
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Assobiotec\, nell'ambito delle attivit&agrave\; del gruppo di l
 avoro Pmi\, organizza un webinar con Matthew Gline\, CFO di Roivant Scienc
 es Ltd\, che illustrer&agrave\; le ultime novit&agrave\; riguardanti nuovi
  modelli di avvio e finanziamento di start-up e PMI biotecnologiche: "Tren
 ds in financing the innovation: why is Roivant Sciences disruptor for phar
 ma-biotech industry?".\n\nAppuntamento su Webex mercoled&igrave\; 7 ottobr
 e alle 14.\n\nLe registrazioni saranno aperte fino a marted&igrave\; 6 ott
 obre alle 12. Alla chiusura delle iscrizioni sar&agrave\; inviato link e c
 odice di accesso Webex.\n\nPer approfondimenti\, ecco un breve profilo di&
 nbsp\;Matthew Gline\n\nMatthew Gline has served as Chief Financial Officer
  of Roivant Sciences\, Inc. since September 2017. Mr. Gline joined Roivant
  in March 2016 and previously served as Senior Vice President\, Finance an
 d Business Operations. From April 2014 to March 2016\, he was a Vice Presi
 dent at Goldman Sachs\, Fixed Income Digital Structuring\, where he focuse
 d on technology and data strategy. Prior to Goldman Sachs\, Mr. Gline was 
 a co-founder of Fourthree\, Inc.\, a risk analytics technology and consult
 ing company. From 2008 to 2012\, he served as Vice President at Barclays\,
  Enterprise Risk Management Advisory\, where he provided analysis for corp
 orate clients related to capital markets access for financing and risk man
 agement. Mr. Gline earned his A.B. in Physics from Harvard University.\n&n
 bsp\;
DTEND:20201007T130000Z
DTSTAMP:20261028T211722Z
DTSTART:20201007T120000Z
LOCATION:webinar
SEQUENCE:0
SUMMARY:Webinar gruppo di lavoro Pmi |Trends in financing the innovation
UID:RFCALITEM639288226420619196
X-ALT-DESC;FMTTYPE=text/html:<p style="text-align: justify\;">Assobiotec\, 
 nell'ambito delle attivit&agrave\; del gruppo di lavoro Pmi\, organizza un
  <strong>webinar con Matthew Gline\, CFO di Roivant Sciences Ltd</strong>\
 , che illustrer&agrave\; le ultime novit&agrave\; riguardanti nuovi modell
 i di avvio e finanziamento di start-up e PMI biotecnologiche: "Trends in f
 inancing the innovation: why is Roivant Sciences disruptor for pharma-biot
 ech industry?".<br />\n<br />\nAppuntamento su Webex mercoled&igrave\; 7 o
 ttobre alle 14.<br />\n<br />\nLe registrazioni saranno aperte fino a mart
 ed&igrave\; 6 ottobre alle 12. Alla chiusura delle iscrizioni sar&agrave\;
  inviato link e codice di accesso Webex.<br />\n<br />\nPer approfondiment
 i\, ecco un breve <strong>profilo di&nbsp\;Matthew Gline</strong><br />\n<
 br />\n<span style="text-align: left\;">Matthew Gline has served as Chief 
 Financial Officer of Roivant Sciences\, Inc. since September 2017. Mr. Gli
 ne joined Roivant in March 2016 and previously served as Senior Vice Presi
 dent\, Finance and Business Operations. From April 2014 to March 2016\, he
  was a Vice President at Goldman Sachs\, Fixed Income Digital Structuring\
 , where he focused on technology and data strategy. Prior to Goldman Sachs
 \, Mr. Gline was a co-founder of Fourthree\, Inc.\, a risk analytics techn
 ology and consulting company. From 2008 to 2012\, he served as Vice Presid
 ent at Barclays\, Enterprise Risk Management Advisory\, where he provided 
 analysis for corporate clients related to capital markets access for finan
 cing and risk management. Mr. Gline earned his A.B. in Physics from Harvar
 d University.</span></p>\n<p>&nbsp\;</p>
END:VEVENT
END:VCALENDAR